Conditions & Treatments

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (CML) is a cancer of the blood in which too many granulocytes, a type of white blood cell, are produced in the bone marrow.

Chronic Myelogenous Leukemia

What is chronic myelogenous leukemia?

Chronic myelogenous leukemia (CML) is a cancer of the blood in which too many granulocytes, a type of white blood cell, build up in the bone marrow. CML is also called chronic myeloid leukemia.   

Normally, bone marrow cells mature into several different types of blood cells. CML affects the young blood cells called blasts that normally develop into a type of white blood cell called granulocytes. The main function of granulocytes is to destroy bacteria. The blasts do not mature, increase to large numbers, and remain in the bone marrow and blood.

Chronic myelogenous leukemia can occur over a period of months or years. A specific chromosome rearrangement is found in the cells of almost all patients with CML. Parts of chromosome #9 and chromosome #22 switch places, so that there is an exchange of genetic material between these 2 chromosomes. This rearrangement changes the position and functions of certain genes, which results in uncontrolled cell growth. The shortened chromosome #22 is often called the Philadelphia chromosome. Nearly all patients with CML have the Philadelphia chromosome in their cells. Other chromosome abnormalities can also be present.

CML occurs mainly in adults and is rare in children. According to the American Cancer Society, about 5,900 cases of CML are expected in the United States in 2013.

What are the symptoms of chronic myelogenous leukemia?

Many people do not have symptoms in the early phase of CML. Instead, the leukemia is found during routine blood tests. When people do have symptoms from CML, the following are the most common. However, each individual may experience symptoms differently. Symptoms may include:

  • Night sweats

  • Weight loss

  • Fever

  • Persistent weakness

  • Fatigue

  • Aches in bones and joints

  • Enlarged spleen

The symptoms of chronic myelogenous leukemia may resemble other blood disorders or medical problems. Always consult your doctor for a diagnosis.

How is chronic myelogenous leukemia diagnosed?

In addition to a complete medical history and physical examination, diagnostic procedures for chronic myelogenous leukemia may include:

  • Blood tests and other evaluation procedures

  • Bone marrow aspiration and/or biopsy. A procedure that involves taking a small amount of bone marrow fluid (aspiration) and/or solid bone marrow tissue (called a core biopsy), usually from the hip bones, to be examined for the number, size, and maturity of blood cells and/or abnormal cells.

Treatment for chronic myelogenous leukemia

Specific treatment for chronic myelogenous leukemia will be determined by your doctor based on:

  • Your age, overall health, and medical history

  • Extent of the disease

  • Your tolerance for specific medications, procedures, or therapies

  • Expectations for the course of the disease

  • Your opinion or preference

Treatment may include:

  • Targeted therapies, such as imatinib, dasatinib, or nilotinib

  • Chemotherapy

  • Biological therapy. This therapy uses the body's immune system to fight cancer.

  • Radiation therapy

  • Stem cell transplantation

  • Splenectomy. Surgery to remove the spleen.

Treatment Programs


Massachusetts General Hospital understands that a variety of factors influence patients' health care decisions. That's just one reason why we're dedicated to ensuring patients understand their diagnosis and treatment options. Because a single option might not serve all patients, we offer a wide range of coordinated treatments and related services across the hospital. Patients should consult with their primary care doctor or other qualified health care provider for medical advice and diagnosis information.

Select a treatment program for more information:



Cancer Center

  • Leukemia
    The Center for Leukemia integrates the best in clinical care, research and support services to provide comprehensive, compassionate care for patients diagnosed with acute or chronic leukemia.
Imaging

  • Cancer Imaging and Intervention
    The Cancer Imaging and Intervention Program at Massachusetts General Hospital Imaging combines leading-edge technology and the expertise of specialty-trained radiologists to provide comprehensive cancer detection and monitoring, plus image-guided treatments for specific types of cancer.
Benson Henry Institute for Mind Body Medicine

  • Consultation
    Come in for a consultation, leave with a comprehensive mind body treatment plan that addresses your stress-related medical condition.
  • Cancer Program
    Designed to supplement the medical treatment of cancer patients by giving them tools to cope with the stress of their illness, make informed choices about treatment, and maintain hope.

The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.

Innovative care at the Cancer Center

Learn more about the latest treatment options for this condition at the Cancer Center